GENEVA, Feb. 4 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Technology Transfer Center, NCI Shady Grove9609 Medical Center Dr., Room 1E-530, MSC 9702Bethesda, MD 20892-9702), SHENZEN XUHUA BIOTECH CO. LTD. (Baoji Road, Bantian StreetRoom 302, Building 1, Zaimao Industrial ParkShenzen 518129) filed a patent application (PCT/US2025/038739) for "OXYNITIDINE DERIVATIVES AS TYROSYL DNA PHOSPHODIESTERASE INHIBITORS AND RADIOSENSITIZERS" on Jul 22, 2025. With publication no. WO/2026/024772, the details related to the patent application was published on Jan 29, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is manage...